Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States. IAJLB. 2023;20(1):20-51. Accessed October 16, 2026. https://iajlb.org/index.php/iajlb/article/view/157